Drug Shortage Report for MIDAZOLAM INJECTION

Last updated on 2022-03-19 History
Report ID 155738
Drug Identification Number 02242904
Brand name MIDAZOLAM INJECTION
Common or Proper name Midazolam Injection 1mg/mL MD Vial 2mL
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) MIDAZOLAM
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 10
ATC code N05CD
ATC description HYPNOTICS AND SEDATIVES
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2022-03-01
Actual start date 2022-03-01
Estimated end date 2022-03-18
Actual end date 2022-03-18
Shortage status Resolved
Updated date 2022-03-19
Company comments We will be experiencing a supply interruption due to a delay in shipping of the drug.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2022-03-19 English Compare
v7 2022-03-18 French Compare
v6 2022-03-18 English Compare
v5 2022-03-18 French Compare
v4 2022-03-18 English Compare
v3 2022-03-02 English Compare
v2 2022-02-28 French Compare
v1 2022-02-28 English Compare

Showing 1 to 8 of 8